SCHEMBL1907244

SCHEMBL1907244

C=CCCC=CCCCCCC

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.71
FAAH O00519 4/20 0.56
TRPV1 Q8NER1 1/20 0.56
ALDH1A1 P00352 1/20 0.55
TOP1 P11387 3/20 0.52
TERT O14746 3/20 0.48
PTPN1 P18031 3/20 0.48
CYP1A2 P05177 2/20 0.48
MAPT P10636 2/20 0.48
CYP2C19 P33261 2/20 0.48
BLM P54132 2/20 0.48
HSD17B10 Q99714 2/20 0.48
FABP4 P15090 2/20 0.48
PPARG P37231 2/20 0.48
KMT2A Q03164 2/20 0.48
PPARD Q03181 2/20 0.48
PPARA Q07869 2/20 0.48
GMNN O75496 1/20 0.48
USP2 O75604 1/20 0.48
LMNA P02545 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3164966 1.00 TSHR (0.71) TSHRFAAHTRPV1ALDH1A1TOP1
SCHEMBL3164970 1.00 TSHR (0.71) TSHRFAAHTRPV1ALDH1A1TOP1
SCHEMBL10635846 1.00 TSHR (0.71) TSHRFAAHTRPV1ALDH1A1TOP1
SCHEMBL16061314 1.00 TSHR (0.71) TSHRFAAHTRPV1ALDH1A1TOP1
SCHEMBL25178894 1.00 TSHR (0.71) TSHRFAAHTRPV1ALDH1A1TOP1
SCHEMBL25181814 1.00 TSHR (0.71) TSHRFAAHTRPV1ALDH1A1TOP1
SCHEMBL10384736 1.00 TSHR (0.71) TSHRFAAHTRPV1ALDH1A1TOP1
SCHEMBL25171276 1.00 TSHR (0.71) TSHRFAAHTRPV1ALDH1A1TOP1
SCHEMBL10384734 1.00 TSHR (0.71) TSHRFAAHTRPV1ALDH1A1TOP1
SCHEMBL6203782 1.00 TSHR (0.71) TSHRFAAHTRPV1ALDH1A1TOP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1268457-A4 REWORKABLE COMPOSITION OF OXIRANE(S) OR THIIRANE(S)-CONTAINING RESIN AND CURING AGENT LOCTITE CORP (US) 2005-07-20 EP claimed
JP-2003529643-A 2003-10-07 JP claimed
EP-1268457-A1 REWORKABLE COMPOSITION OF OXIRANE(S) OR THIIRANE(S)-CONTAINING RESIN AND CURING AGENT LOCTITE CORPORATION (US) 2003-01-02 EP claimed
WO-2001074798-A1 REWORKABLE COMPOSITION OF OXIRANE(S) OR THIIRANE(S)-CONTAINING RESIN AND CURING AGENT LOCTITE CORPORATION (US) 2001-10-11 WO claimed
WO-2023085299-A1 CATIONIC LIPID 武田薬品工業株式会社 2023-05-19 WO disclosed
CN-107922517-B Non-extrusion process for functionalizing low viscosity polyolefins 陶氏环球技术有限责任公司 2022-02-08 CN disclosed
CN-107892959-B Vanadium inhibitor, preparation method of vanadium inhibitor, vanadium-inhibiting composition and application thereof, and preparation method of vanadium-inhibiting composition 宁波广昌达新材料有限公司 2020-03-27 CN disclosed
CN-107892959-A Vanadium-inhibiting agent, the preparation method of vanadium-inhibiting agent, suppression vanadium composition and its application, the preparation method for pressing down vanadium composition 宁波广昌达新材料有限公司 2018-04-10 CN disclosed
US-8269038-B2 Process for production of sulfonic acid ester WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) 2012-09-18 US disclosed
EP-1477498-B1 PROCESS FOR PRODUCING MODIFIED BUTENE-1 POLYMER AND MODIFIED BUTENE-1 POLYMER OBTAINED BY THE PROCESS IDEMITSU KOSAN CO (JP) 2011-05-11 EP disclosed
US-20100041916-A1 PROCESS FOR PRODUCTION OF SULFONIC ACID ESTER WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) 2010-02-18 US disclosed
EP-2067770-A1 PROCESS FOR PRODUCTION OF SULFONIC ACID ESTER Wako Pure Chemical Industries, Ltd. (JP) 2009-06-10 EP disclosed
US-7420023-B2 Process for producing modified butene-1 polymer and modified butene-1 polymer obtained by the process IDEMITSU KOSAN CO., LTD. (JP) 2008-09-02 US disclosed
US-20050245710-A1 Process for producing modified butene-1 polymer and modified butene-1 polymer obtained by the process IDEMITSU KOSAN CO., LTD. (JP) 2005-11-03 US disclosed
EP-1477498-A1 PROCESS FOR PRODUCING MODIFIED BUTENE-1 POLYMER AND MODIFIED BUTENE-1 POLYMER OBTAINED BY THE PROCESS IDEMITSU PETROCHEMICAL CO., LTD. (JP) 2004-11-17 EP disclosed
EP-0611377-B1 PROCESS FOR PRODUCING POLYOLEFIN EXXONMOBIL CHEM PATENTS INC (US) 2001-08-01 EP disclosed
US-4784784-A ESTERS OF POLYOXYETHYLENE GLYCOL MODIFIED WITH POLYALKYLENE PENNZOIL PRODUCTS COMPANY (US) 1988-11-15 US disclosed
US-4689166-A Succinic acid esters and hydraulic fluids thereform PENNZOIL PRODUCT COMPANY (US) 1987-08-25 US disclosed
EP-0212153-A1 Low molecular weight polyalkenamers and their use HÜLS AKTIENGESELLSCHAFT (DE) 1987-03-04 EP disclosed
US-4450281-A Process for the preparation of a polyalkenyl succinic anhydride CHEVRON RESEARCH COMPANY (US) 1984-05-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100041916-A1 PROCESS FOR PRODUCTION OF SULFONIC ACID ESTER SULT1A1, SULT2A1, STS TSHR 1491/4885FAAH 417/4885TRPV1 1855/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.